Filing Flows › Abeona Therapeutics (ABEO) › Q2 2026 › vs Q1 2026
Abeona Therapeutics (ABEO) Q2 2026 vs Q1 2026 (quarter over quarter)
Abeona Therapeutics's revenue rose $2.7M (+31%) from $8.7M in Q1 2026 to $11.4M in Q2 2026.
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $11.4M | $8.7M | $2.7M | +31% |
| Net loss | $20.2M | $17.1M | $3.1M | +18% |
| Costs & expenses | $31.6M | $31.8M | −$184K | -0.6% |
| Operating costs | $25.0M | $31.8M | −$6.7M | -21% |
| Interest & other, net | $6.5M | −$6.0M | $12.5M | — |
| Cost of revenue | $4.2M | $2.7M | $1.5M | +55% |
| Research & development | $5.0M | $9.6M | −$4.5M | -47% |
| SG&A | $15.8M | $19.5M | −$3.7M | -19% |
| Operating cash sources | $21.5M | $23.5M | −$1.9M | -8% |
| Depreciation & amortization | $665K | $690K | −$25K | -4% |
| Share-based compensation | $3.4M | $3.0M | $412K | +14% |
| Cash used in operations | $17.5M | $19.8M | −$2.3M | -12% |
| Net loss absorbed | $20.2M | $17.1M | $3.1M | +18% |
| Working capital & other | $1.3M | $6.4M | −$5.0M | -79% |
Questions
How much did Abeona Therapeutics's revenue grow quarter over quarter in Q2 2026?
Abeona Therapeutics's revenue rose $2.7M (+31%) from $8.7M in Q1 2026 to $11.4M in Q2 2026.